Family Medicine Doctors in Gretna, NE Accepting Medicare

6 Family Medicine doctors found. Showing 1 - 6

Derek Logan Marshall, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 102 W Gruenther Rd, Gretna, NE 68028 Phone: 402-332-2772

Carmella N Imig, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 102 W Gruenther Rd, Gretna, NE 68028 Phone: 402-332-2772    Fax: 402-332-5446

Dr. Ryan Bruce Isherwood, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 11946 Standing Stone Dr, Gretna, NE 68028 Phone: 402-815-4500    Fax: 402-815-4510

William Lowndes, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 102 W Highway 370, Gretna, NE 68028 Phone: 402-332-2772

Karen S Staack, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 102 W Gruenther Rd, Gretna, NE 68028 Phone: 402-332-2772    Fax: 402-332-5446

Kathleen A Archer, ARNP Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 11820 Standing Stone Dr, Gretna, NE 68028 Phone: 402-332-3903    Fax: 402-391-3076

News Archive

Shire announces results of Vyvanse Phase 2 signal finding study for Major Depressive Disorder

Shire plc the global specialty biopharmaceutical company, today announced results from a Phase 2 signal finding study of Vyvanse(R) [lisdexamfetamine dimesylate (or SPD489)] in patients who have had residual symptoms of depression following treatment with LEXAPRO(escitlopram) for Major Depressive Disorder (MDD).

Progress in Anadys Pharmaceuticals' Phase II study of ANA598 announced

Anadys Pharmaceuticals, Inc. today announced that ANA598 dosing has been completed in the first dose cohort, 200 mg bid, in an ongoing Phase II study of ANA598 in combination with pegylated interferon and ribavirin (SOC) in HCV patients.

Controversial hormone could fight against recurring breast cancers

An international team of researchers involving the University of Adelaide is tackling the controversy over what some scientists consider to be a "harmful" hormone, arguing that it could be a game changer in the fight against recurring breast cancers that are resistant to standard treatments.

Blood levels of vitamin folate in women of childbearing age decreasing

From 1999 through 2004 there was an 8% to 16% decline in the level of the vitamin folate in the blood of U.S. women of childbearing age, according to a study published in the Jan. 5 issue of CDC's Morbidity and Mortality Weekly Report, the AP/Houston Chronicle reports (Stobbe, AP/Houston Chronicle, 1/4).

Transition to virtual care during COVID-19 does not limit glycemic outcomes of diabetes inpatients

Data collected over a 15-week period showed that using virtual care to manage diabetes patients in the hospital does not have a negative impact on their glycemic outcomes.

Read more Medical News

› Verified 8 days ago